You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

DC Vaccine

Showing 1 - 25 of 8,752
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ovarian Carcinoma Trial (PEP-DC1, OC-DC, PEP-DC2)

Not yet recruiting
  • Ovarian Carcinoma
  • PEP-DC1
  • +3 more
  • (no location specified)
Jan 26, 2023

Solid Tumor Trial in Shanghai (DC cells)

Recruiting
  • Solid Tumor
  • DC cells
  • Shanghai, Shanghai, China
    Shanghai Mengchao Cancer Hospital
Aug 23, 2023

Tumor Vaccine Benefit for Gliomas

Recruiting
  • Glioma
  • DC vaccine
  • Shanghai, China
    Huashan Hospital，Fudan University
Sep 12, 2023

Esophageal Cancer, Pancreas Cancer, Ovarian Cancer Trial in Edegem (IL15-transpresenting WT1-targeted Dendritic Cell Vaccine)

Not yet recruiting
  • Esophageal Cancer
  • +3 more
  • IL15-transpresenting WT1-targeted Dendritic Cell Vaccine
  • Edegem, Belgium
    Antwerp University Hospital
Jul 19, 2023

Malignant Glioma, Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in Miami (biological, drug, procedure)

Completed
  • Malignant Glioma
  • +3 more
  • Dendritic Cell Vaccine
  • +3 more
  • Miami, Florida
    University of Miami
Jul 19, 2022

Colorectal Cancer Trial in Philadelphia (DC vaccine)

Recruiting
  • Colorectal Cancer
  • DC vaccine
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Feb 21, 2022

Solid Tumor, Adult, EphA2 Overexpression, KRAS G12V Trial in Beijing (KRAS-EphA-2-CAR-DC, Abraxane, Cyclophosphamide)

Recruiting
  • Solid Tumor, Adult
  • +4 more
  • KRAS-EphA-2-CAR-DC
  • +3 more
  • Beijing, Beijing, China
    Biotherapeutic Department of Chinsese PLA Gereral Hospital
Nov 29, 2022

Solid Tumor, Adult, Lymphoma, EphA2 Overexpression Trial in Beijing (TP53-EphA-2-CAR-DC, Abraxane, Cyclophosphamide)

Recruiting
  • Solid Tumor, Adult
  • +6 more
  • TP53-EphA-2-CAR-DC
  • +3 more
  • Beijing, Beijing, China
    Biotherapeutic Department of Chinsese PLA Gereral Hospital
Nov 29, 2022

Melanoma Trial in Philadelphia (Mature dendritic cell (DC) vaccine, Cyclophosphamide 300mg/m^2, Pembrolizumab)

Active, not recruiting
  • Melanoma
  • Mature dendritic cell (DC) vaccine
  • +2 more
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Feb 2, 2023

Glioblastoma Trial in Guangzhou (Personalized cellular vaccine)

Completed
  • Glioblastoma
  • Personalized cellular vaccine
  • Guangzhou, Guangdong, China
    Guangdong 999 Brain Hospital
May 23, 2022

Breast Cancer Trial in Tampa, Philadelphia (HER-2 pulsed Dendritic Cell Vaccine)

Active, not recruiting
  • Breast Cancer
  • HER-2 pulsed Dendritic Cell Vaccine
  • Tampa, Florida
  • +1 more
Mar 23, 2022

Esophageal Squamous Cell Carcinoma Trial in Chengdu (OCDC vaccine; NeoDC vaccine)

Not yet recruiting
  • Esophageal Squamous Cell Carcinoma
  • OCDC vaccine; NeoDC vaccine
  • Chengdu, Sichuan, China
    West China Hospital
Mar 30, 2022

Pancreatic Ductal Adenocarcinoma Trial in Philadelphia (mDC3/8-KRAS Vaccine)

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • mDC3/8-KRAS Vaccine
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Apr 4, 2022

Breast Cancer Trial in Tampa, Philadelphia (HER-2 pulsed Dendritic Cell Vaccine)

Active, not recruiting
Has Results
  • Breast Cancer
  • HER-2 pulsed Dendritic Cell Vaccine
  • Tampa, Florida
  • +1 more
Feb 14, 2022

Carcinoma, Esophagus Cancer Trial in Chengdu (Tumor antigen-sensitized DC vaccine)

Not yet recruiting
  • Carcinoma
  • Esophagus Cancer
  • Tumor antigen-sensitized DC vaccine
  • Chengdu, Sichuan, China
    West China Hospital
Aug 21, 2021

Advanced Malignant Solid Tumors Trial in Nanchang (Neoantigen peptide vaccine, Neoantigen-based DC immune preparation)

Not yet recruiting
  • Advanced Malignant Solid Tumors
  • Neoantigen peptide vaccine
  • Neoantigen-based DC immune preparation
  • Nanchang, Jiangxi, China
    First Affiliated Hospital of Nanchang University
Mar 1, 2023

Breast Cancer Trial in Dallas (LA TNBC: DC vaccine+Preop chemo, ER+/HER2-BC:DC vaccine+Preop chemo)

Completed
Has Results
  • Breast Cancer
  • LA TNBC: DC vaccine+Preop chemo
  • ER+/HER2-BC:DC vaccine+Preop chemo
  • Dallas, Texas
    Baylor University Medical Center
Oct 7, 2021

Hepatocellular Carcinoma, Hepatocellular Cancer, Colorectal Cancer Trial in Singapore (Neoantigen Dendritic Cell Vaccine,

Recruiting
  • Hepatocellular Carcinoma
  • +4 more
  • Singapore, Singapore
    National Cancer Center Singapore
Aug 17, 2022

Refractory Leukemia, Relapsed Leukemia, Acute Myelogenous Leukemia Trial in Miami (STING-Dependent Activators (STAVs) Loaded

Not yet recruiting
  • Refractory Leukemia
  • +4 more
  • STING-Dependent Activators (STAVs) Loaded Autologous Leukemic Cells
  • Dendritic Cell Vaccine
  • Miami, Florida
    University of Miami
Jan 23, 2023

Glioblastoma Multiforme of Brain Trial in Beijing (Autologous dendritic cells pulsed with multiple neoantigen peptides.,

Recruiting
  • Glioblastoma Multiforme of Brain
  • Autologous dendritic cells pulsed with multiple neoantigen peptides.
  • Temozolomide adjuvant chemotherapy
  • Beijing, Beijing, China
    Beijing Tiantan Hospital
Jan 13, 2022

Pancreatic Adenocarcinoma Trial in Lausanne (Autologous Dendritic Cell Vaccine Loaded with Personalized Peptides (PEP-DC

Recruiting
  • Pancreatic Adenocarcinoma
  • Autologous Dendritic Cell Vaccine Loaded with Personalized Peptides (PEP-DC vaccine)
  • Lausanne, Vaud, Switzerland
    CHUV Oncology Department
Jun 23, 2022

NSCLC Trial in Lausanne (Autologous dendritic cell vaccine loaded with personalized peptides (PEP-DC vaccine), Low dose

Recruiting
  • Non-small Cell Lung Cancer
  • Autologous dendritic cell vaccine loaded with personalized peptides (PEP-DC vaccine)
  • Low dose cyclophosphamide
  • Lausanne, Vaud, Switzerland
    CHUV Oncology Department
Jan 17, 2022

Cancer of Ovary, Cancer of the Ovary, Tumors, Ovarian Trial in Pittsburgh (Cisplatin + celecoxib + DC vaccine, Cisplatin + CKM +

Suspended
  • Cancer of Ovary
  • +5 more
  • Cisplatin + celecoxib + DC vaccine
  • Cisplatin + CKM + Celecoxib + DC Vaccine
  • Pittsburgh, Pennsylvania
  • +1 more
Dec 15, 2021

Breast Tumors, Breast Cancer, Adenocarcinomas Trial run by the NCI (AdHER2/neu DC Vaccine)

Completed
Has Results
  • Breast Neoplasms
  • +3 more
  • Adenoviral Transduced Autologous Human Epidermal Growth Factor Receptor (AdHER)2/neu Dendritic Cell (DC) Vaccine
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 12, 2022

Advanced Lung Carcinoma Trial in Beijing (LK101 injection (personlized neoantigen pulsed DC vaccine ), Pembrolizumab,

Recruiting
  • Advanced Lung Carcinoma
  • LK101 injection (personlized neoantigen pulsed DC vaccine )
  • +2 more
  • Beijing, Beijing, China
    Cancer hospital Chinese Academy of Medical Sciences
May 23, 2023